Author(s):
Deepak Sarangi, Subhashree Mallick, Anjum Ara, Sanjeeb Kumar Sahoo, Rabinarayan Rana
Email(s):
sarangi.dipu@gmail.com
DOI:
10.52711/0975-4377.2021.00034 
Address:
Deepak Sarangi, Subhashree Mallick, Anjum Ara, Sanjeeb Kumar Sahoo, Rabinarayan Rana
Department of Pharmaceutics, Roland Institute of Pharmaceutical Sciences, Brahmapur, Odisha, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2021
ABSTRACT:
Olmesartan Medoxomil is an AT1 subtype selected angiotensin-II receptor antagonist approved for the treatment of hypertension. It has low water solubility, so the current effort is being made to enhance the solubility of the Olmesartan by inclusion complex and to incorporate them into tablets by direct compression. Complexing agent like Beta cyclodextrin and polyvinyalpyrrolidone has been used for complexation method. FT-IR studies have shown that there is no link between drugs and complexing agents. Among all methods, the inclusion complex (OLBCD 3) containing the drug: Beta cyclodextrin in a 1: 3 ratio showed rapid drug release (87.41% within 30 minutes) and post compression parameters are within limits. All the values obtained from pre compression and post compression parameters meets the legal requirements for tablets. Stability studies of batch no OLBCD 3 shows no significant change. Therefore, it can be concluded that the structure was stable.
Cite this article:
Deepak Sarangi, Subhashree Mallick, Anjum Ara, Sanjeeb Kumar Sahoo, Rabinarayan Rana. An Assessment of Olmesartan Medoxomil Tablet by Inclusion Complex Technique. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):193-7. doi: 10.52711/0975-4377.2021.00034
Cite(Electronic):
Deepak Sarangi, Subhashree Mallick, Anjum Ara, Sanjeeb Kumar Sahoo, Rabinarayan Rana. An Assessment of Olmesartan Medoxomil Tablet by Inclusion Complex Technique. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):193-7. doi: 10.52711/0975-4377.2021.00034 Available on: https://rjpdft.com/AbstractView.aspx?PID=2021-13-3-5
REFERENCES:
1. Panchal DM, Tiwari AK. A research on improvisation in dissolution of Olmesartan medoxomil by enhancing its solubility using solid dispersion techniques. World J Pharma Res 2013; 2: 1793-816.
2. Chaudhary A, Nagaich U, Gulati N, Sharma VK., Khosa R.L. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical andchemical modifications: A recent review. J Adv Pharm Edu Res 2012; 2: 32- 67.
3. Joshi V, Ahmed M.G, Suresh S, Kowti R. A comparative study: solution stability and dissolution behavior of solid dispersions Curcumin. Indian J Novel Drug Delivery. 2010; 2: 88-95.
4. Sinha S, Ali M, Sanjula B, Ahuja A, Kumar A, Ali J. Solid Dispersion as an approach for bioavailability enhancement of poorly water-soluble drug Ritonavir. AAPS Pharm Sci Tech. 2010; 11: 518-27.
5. Dhirendra K, Lewis S, Udupa N, Atin k. Solid dispersion: A review. Pak J Pharm Sci. 2009; 22: 234-46.
6. Chandrakant DS, Danki LS, Abdul S, Mallikarjun B. Preparation and evaluation of inclusion complexes of water insoluble drug. Int J Res Pharm Biomedical Sci. 2011; 2: 1599-1616.
7. Mehta H, Akhilesh D, Prabhakar P, Kamath JV. Enhancement of solubility by complexation with cyclodextrin and nanocrystallization. Int Res J Pharm. 2013; 3: 100-05.
8. Thakkar HP, Patel BV, Thakkar SP. Development and characterization of nanosuspension of olmesartan medoxomil for bioavailability enhancement. J Pharm Bio Allied Sci. 2011; 3: 426–34.
9. Sathali AAH, Jayalakshmi J. Enhancement of solubility and dissolution rate of olmesartan medoxomil by solid dispersion technique. J Curr Chem Pharm Sc. 2013; 3: 123-34.
10. Chowdary KPR., Ravi Shankar K, Ruth MM. Enhancement of dissolution rate of olmesartan by solid dispersion in Crosspovidone and Poloxamer 188 alone and in combination. World J Pharm Res 2014; 3: 4717-27.
11. Sasidhar RLC, Vidyadhara S, Maheswari GV, Deepti B, P. Srinivasa BP. Solubility and dissolution rate enhancement of olmesartan medoxomil by complexation and development of mouth dissolving tablets. Adv Bio Res 2013; 7: 32-41.
12. Prabhu P, Nayari H, Ahmed GM, Satayaranarayana D, Charyulu RN, Subrahmanyam EVS, Bhat KI. Synthesis and investigation of colon specific polymeric prodrug of Ibuprofen with cyclodextrin. Asian J Chem 2009; 21: 6689-94.